ScreenerHero

POXEL Poxel S.A.

EPA · FR · Healthcare · Biotechnology · poxelpharma.com
0.1374EUR-8.40%Mkt Cap: 9.93M $P/E: —

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases. It also develops treatments for rare metabolic diseases and associated…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap9.93M USD
Enterprise Value73.92M USD
Revenue (TTM)8.32M USD
Gross Profit4.33M USD
Net Income (TTM)-14.85M USD
Revenue/Share0.14 EUR
Last Price0.1374 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees5
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0012432516
Valuation
P/E (Trailing)—
P/E (Forward)0.16
PEG—
EV/EBITDA—
EV/Revenue8.88
P/S1.30
P/B-0.13
EPS (TTM)-0.26
EPS (Forward)0.92
52W Range
0.13022% of range0.4800
52W High0.4800 EUR
52W Low0.1302 EUR
Profitability
Gross Margin52.02%
Oper. Margin-89.97%
EBITDA Margin0.00%
Profit Margin-178.45%
ROE—
ROA-20.72%
Growth
Revenue Growth87.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.19M USD
CapEx (TTM)—
FCF Margin-133.37%
FCF Yield-111.75%
Net Debt65.17M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.96
Current Ratio0.26
Quick Ratio0.23
Book Value/Sh-1.14 EUR
Cash/Share0.04 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.66.51M
Float—
Insiders5.73%
Institutions0.00%
Technical
SMA 500.1916 (-28.3%)
SMA 2000.2330 (-41.0%)
Beta1.28
S&P 52W Chg14.58%
Avg Vol (30d)411.09K
Avg Vol (10d)514.88K
Technical Indicators
RSI (14)26.8
MACD-0.0102
MACD Signal-0.0075
MACD Hist.-0.0028
BB Upper0.1993 EUR
BB Middle0.1729 EUR
BB Lower0.1466 EUR
BB Width30.46%
ATR (14)0.0096 EUR
Vol Ratio (20d)2.72x